leyi
lin
md
catherin
f
decker
md
facp
fidsa
averag
adult
experi
upper
respiratori
infect
urti
year
lead
caus
physician
visit
miss
day
work
urti
one
common
medic
condit
affect
athlet
athlet
often
close
contact
other
team
locker
room
practic
travel
increas
risk
infect
addit
stress
train
travel
competit
environment
exposur
suppress
athlet
immun
system
question
whether
exercis
increas
risk
urti
studi
sever
investig
remain
controversi
studi
vari
wide
respect
subject
method
exercis
load
sever
epidemiolog
studi
observ
case
seri
support
j
curv
relationship
exercis
risk
urti
model
suggest
moder
exercis
improv
immun
function
compar
sedentari
person
prolong
highintens
exercis
may
impair
immun
function
releas
stress
hormon
window
period
suppress
cellmedi
immun
often
follow
strenuou
exercis
doserespons
relationship
exercis
load
risk
urti
difficult
prove
report
hour
moder
activ
daili
improv
overal
health
individu
decreas
urti
compar
sedentari
individu
howev
case
extrem
physic
exert
studi
marathon
racer
run
greater
kmwk
appear
lead
respiratori
infect
endur
event
marathon
associ
infect
week
post
race
howev
worldclass
athlet
may
abl
toler
heavi
physiolog
demand
without
signific
immun
suppress
unfortun
random
control
trial
difficult
conduct
current
avail
studi
reinforc
complex
causal
associ
exercis
suscept
respiratori
tract
infect
urti
account
major
lost
train
time
athlet
urti
benign
selflimit
incub
period
hour
typic
last
week
symptom
nonspecif
includ
sore
throat
cough
rhinorrhea
nasal
congest
headach
bodi
ach
fever
virus
frequent
caus
urti
common
virus
includ
rhinovirus
cornavirus
adenoviru
parainfluenza
viru
human
respiratori
syncyti
viru
metapneumoviru
caus
sever
ill
children
elderli
peopl
immunocompromis
may
also
caus
urti
studi
evalu
athlet
hour
typic
uri
symptom
found
caus
agent
case
use
varieti
isol
techniqu
includ
serolog
cultur
polymeras
chain
reaction
pcr
nasopharyng
saliva
blood
sampl
studi
rhinoviru
often
isol
follow
adenoviru
mycoplasma
pneumonia
parainfluenza
hemophilu
influenza
streptococcu
pyogen
staphylococcu
aureu
unclear
whether
symptom
last
longer
athlet
epidemiolog
studi
report
conflict
result
viral
urti
transmit
direct
contact
andor
aerosol
viral
particl
person
person
spread
depend
amount
time
peopl
spend
togeth
close
commun
secondari
attack
rate
high
hand
hand
contact
common
mean
transmiss
follow
spread
infect
inocul
viru
nose
eye
suscept
person
proper
hand
wash
athlet
highli
encourag
import
prevent
measur
physic
examin
nonspecif
diagnosi
made
base
clinic
present
symptom
viral
cultur
rare
indic
uncompl
viral
urti
outpati
set
effect
antivir
therapi
virus
often
implic
treatment
viral
urti
support
symptom
relief
use
decongest
antihistamin
need
return
play
limit
data
exist
support
welldefin
timelin
return
play
decis
return
play
made
case
case
basi
gener
consensu
favor
continu
train
neck
symptom
rhiniti
mild
headach
rest
recommend
cough
fever
myalgia
exercis
acut
infect
caus
seriou
complic
increas
risk
recurr
athlet
concern
decondit
awar
day
rest
signific
effect
fit
common
cold
selflimit
prolong
worsen
urti
symptom
may
suggest
acut
bacteri
sinus
develop
adult
viral
urti
streptococcu
pneumonia
streptococci
h
influenza
moraxella
catarrhali
aureu
common
bacteri
caus
sinus
acut
bacteri
sinus
often
follow
viral
allerg
rhiniti
symptom
may
includ
nasal
congest
purul
nasal
discharg
fever
headach
facial
pain
maxillari
tooth
discomfort
antibiot
consid
symptom
last
day
sever
symptom
fever
facial
pain
perioribit
swell
amoxicillin
prefer
emerg
resist
led
use
amoxicillinclavulan
augmentin
macrolid
fluoroquinolon
provid
consid
local
resist
pattern
patient
risk
factor
prescrib
antibiot
symptomat
treatment
antihistamin
decongest
nasal
steroid
may
also
benefici
acut
pharyng
tonsil
account
approxim
outpati
antibiot
use
million
clinic
visit
annual
pharyng
may
viral
bacteri
origin
may
indistinguish
clinic
present
sore
throat
due
virus
coronaviru
rhinoviru
adenoviru
enteroviru
influenza
parainfluenza
herp
simplex
viru
epsteinbarr
viru
ebv
hiv
bacteri
pathogen
includ
group
betahemolyt
strep
gabh
bacteri
pathogen
includ
mycoplasma
chlamydia
corynebacterium
anaerob
streptococci
neisseria
gonorrhoea
sexual
activ
patient
gabh
account
approxim
case
acut
pharyng
adult
much
higher
rate
children
import
infect
athlet
abil
spread
quickli
person
person
via
contact
droplet
saliva
nasal
secret
crowd
area
locker
room
school
barrack
favor
spread
interestingli
virul
bacteria
may
enhanc
process
spread
natur
select
much
lower
children
carriag
rate
among
adult
like
around
vari
popul
untreat
convalesc
patient
transmit
infect
also
prompt
use
antibiot
minim
secondari
spread
centor
criteria
fever
lack
cough
pharyngotonsillar
exud
tender
anterior
cervic
adenopathi
distinguish
bacteri
viral
case
thu
rapid
test
cultur
perform
suspect
case
addit
pharyng
find
gabh
infect
scarlet
rash
may
appear
bodi
identif
treatment
gabh
import
minim
risk
complic
treatment
prevent
lymphaden
abscess
sinus
bacteremia
pneumonia
acut
rheumat
fever
prevent
post
streptococc
glomerulonephr
greater
hour
close
contact
index
patient
week
preced
symptom
associ
carriag
infect
screen
treatment
may
consid
case
symptomat
relief
includ
use
nonsteroid
antiinflammatori
drug
appropri
case
acut
pharyng
except
case
gabh
antibiot
indic
return
play
athlet
suspect
confirm
acut
gabh
pharyng
consid
contagi
antibiot
therapi
hour
recommend
particip
play
athlet
may
slightli
higher
risk
pneumonia
especi
winter
season
howev
recurr
lower
respiratori
tract
infect
prompt
evalu
underli
immunodefici
bacteri
viral
rare
fungal
caus
consid
although
latter
concern
athlet
travel
area
endem
fungi
pneumonia
common
caus
bacteri
pneumonia
typic
organ
includ
h
influenza
aureu
group
betahemolyt
streptococci
catarrhali
atyp
organ
includ
pneumonia
chlamydophila
pneumonia
chlamydia
psittaci
legionella
cough
sputum
product
short
breath
chest
pain
fever
common
present
symptom
pneumonia
athlet
present
respiratori
symptom
import
vital
sign
review
close
help
determin
outpati
therapi
appropri
inpati
monitor
warrant
abnorm
auscultatori
find
physic
examin
infiltr
chest
radiograph
indic
pneumonia
help
differenti
pneumonia
inflamm
pulmonari
parenchyma
bronchiti
sputum
cultur
serolog
urinari
antigen
help
diagnost
tool
commonli
use
urinari
antigen
includ
pneumococcu
legionella
pneumophila
type
histoplasmosi
macrolid
doxycyclin
recommend
previou
healthi
individu
communityacquir
pneumonia
risk
factor
resist
recent
antimicrobi
use
recent
hospit
alcohol
immunosuppress
exist
respiratori
quinolon
betalactam
macrolid
combin
recommend
patient
continu
fever
complic
pleural
effus
empyema
consid
reactiv
airway
may
also
occur
communityacquir
pneumonia
may
last
week
month
symptom
may
manag
bronchodil
therapi
pneumonia
caus
upper
lower
respiratori
tract
infect
especi
age
group
attack
rate
among
famili
member
report
near
immun
tend
longlast
pertin
athlet
live
close
quarter
incub
time
week
gradual
onset
respiratori
symptom
usual
preced
headach
fever
cough
minim
sputum
product
confirm
diagnosi
difficult
rapid
pcr
sputum
sampl
limit
sensit
igm
serolog
often
fail
develop
adult
pcr
serolog
combin
recommend
fastidi
natur
mycoplasma
make
vitro
growth
difficult
chest
radiograph
find
diffus
interstiti
involv
extrapulmonari
involv
bullou
myring
arthriti
skin
erupt
may
aid
diagnosi
evid
suggest
mycoplasma
pneumonia
may
contribut
develop
asthma
symptom
viral
pneumonia
due
influenza
b
virus
mitig
use
neuraminidas
inhibitor
oseltamivir
zanamivir
given
within
hour
agent
document
activ
virus
associ
pneumonia
coccidiomycosi
histoplasmosi
blastomycosi
potenti
respiratori
pathogen
athlet
train
compet
area
endem
fungi
howev
infect
asymptomat
asthma
allergi
may
common
caus
chronic
cough
athlet
health
care
provid
awar
recent
increas
incid
bordetella
pertussi
infect
young
adult
persist
cough
week
adult
may
due
b
pertussi
case
diagnosi
made
pcr
nasopharyng
aspir
pertussi
highli
communic
reach
household
among
unimmun
contact
immun
contact
macrolid
trimethoprimsulfamethoxazol
effect
agent
athlet
confirm
probabl
pertussi
isol
day
begin
treatment
athlet
known
close
contact
known
suspect
case
pertussi
receiv
prophylact
antibiot
therapi
macrolid
return
play
athlet
treat
appropri
therapi
usual
improv
symptom
hour
athlet
afebril
return
competit
train
resum
slowli
prevent
spread
among
athlet
case
influenza
athlet
kept
train
room
practic
competit
day
onset
symptom
prevent
athlet
immun
season
influenza
addit
booster
dose
acellular
pertussi
vaccin
avail
tdap
administ
young
adult
reduc
transmiss
pertussi
pneumococc
polysaccharid
vaccin
recommend
athlet
asthma
cochlear
implant
chronic
medic
condit
prevent
infectioncontrol
measur
taken
avoid
infect
includ
regular
hand
wash
minim
contact
sick
person
avoid
share
person
item
adequ
rest
proper
nutrit
vital
healthi
immun
system
disclaim
opinion
assert
contain
herein
author
constru
offici
reflect
view
depart
defens
depart
navi
naval
servic
larg
opinion
assert
contain
herein
privat
view
author
constru
offici
reflect
view
us
depart
armi
us
depart
defens
